Noelia Ferruz Capapey
Noelia Ferruz Capapey
Universität Bayreuth
Verified email at
TitleCited byYear
Emergence of multiple EGFR extracellular mutations during cetuximab treatment in colorectal cancer
S Arena, B Bellosillo, G Siravegna, A Martínez, I Cañadas, L Lazzari, ...
Clinical cancer research 21 (9), 2157-2166, 2015
Binding kinetics in drug discovery
N Ferruz, G De Fabritiis
Molecular informatics 35 (6-7), 216-226, 2016
Insights from fragment hit binding assays by molecular simulations
N Ferruz, MJ Harvey, J Mestres, G De Fabritiis
Journal of chemical information and modeling 55 (10), 2200-2205, 2015
Multibody cofactor and substrate molecular recognition in the myo-inositol monophosphatase enzyme
N Ferruz, G Tresadern, A Pineda-Lucena, G De Fabritiis
Scientific reports 6 (1), 1-10, 2016
Computational modeling of an epidermal growth factor receptor single-mutation resistance to cetuximab in colorectal cancer treatment
I Buch, N Ferruz, G De Fabritiis
Journal of chemical information and modeling 53 (12), 3123-3126, 2013
Dopamine D3 receptor antagonist reveals a cryptic pocket in aminergic GPCRs
N Ferruz, S Doerr, MA Vanase-Frawley, Y Zou, X Chen, ES Marr, ...
Scientific Reports 8 (1), 897, 2018
Reranking docking poses using molecular simulations and approximate free energy methods
G Lauro, N Ferruz, S Fulle, MJ Harvey, PW Finn, G De Fabritiis
Journal of chemical information and modeling 54 (8), 2185-2189, 2014
Strategies for designing non-natural enzymes and binders
H Lechner, N Ferruz, B Höcker
Current opinion in chemical biology 47, 67-76, 2018
Understanding ligand-receptor recognition by means of high-throughput molecular dynamics: a perspective for drug discovery
NF Capapey
Universitat Pompeu Fabra, 2016
A Plückthun, MP Vogt, B Höcker, F Schwägerl, J Kynast, H Lechner, ...
Receptor design using molecular dynamics (MD)
N Ferruz
HPC at RRZE, 51, 0
The system can't perform the operation now. Try again later.
Articles 1–11